PATENT CLAIM ANALYSIS

Application Number: 16011378
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["514", "001000"]

Abstract:
The present invention relates to compositions comprising therapeutic and/or diagnostic anionic agents together with cationic peptides and their use in methods for delivering the anionic agents to bladder cells.

Claim (Index 9):
The method of  claim 6 , where the mass ratio of protamine to antisense oligonucleotide directed against nerve growth factor is about 10:1 respectively.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 94.0
- Lexical Diversity: 1.11111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14846536', '10835151', '15056386', '10018103', '15698486']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6951857702696639
- 35 USC 102 Novelty (BERT): 0.6032003274362963
- Combined Prediction Score: 0.6859872259863271
- Mean Citation Score: 296.71399800000006
- Max Citation Score: 537.62634
- Similarity Product: 462.958863446846

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test